journal article·2024-12Open access

Simultaneous targeting and suppression of heat shock protein 60 to overcome heat resistance and induce mitochondrial death of tumor cells in photothermal immunotherapy

Yiling Meng, Tao Wen, Xuanxin Liu, Aiyun Yang, Jie Meng, Jian Liu, Jianhua Wang, Haiyan Xu

Abstract

As the most aggressive and metastatic subtype of breast cancer, clinical demands of triple negative breast cancer (TNBC) have far not been met. Heat shock protein 60 (HSP60) is over expressed in tumor cells and impair the efficacy of photothermal therapy. In this work, a conjugate composed of self-designed peptide targeting HSP60 and gold nanorods was constructed, referred to as AuNR-P17. Results showed that AuNR-P17 was able to simultaneously down regulate the level of HSP60 and locate in the mitochondria where HSP60 is enriched in the tumor cells of TNBC, which also impeded the interaction between HSP60 and integrin α 3 , thereby reducing the tumor cells' heat tolerance and metastatic capabilities. At the same time, AuNR-P17 induced remarkable mitochondrial apoptosis when exposed to the laser irradiation of 808 nm. The dual functions of AuNR-P17 led to the decrement of BCL-2 and the activation of p53 and cleaved caspase-3. The danger associated molecular patterns (DAMPs) generated from the mitochondrial apoptosis elicited strong and long-term specific immune responses against TNBC in vivo and ultimately inhibited the tumor metastasis and recurrence with significantly prolonged survival (>100 days) on TNBC mice. In conclusion, this study demonstrated HSP60 a promising potential therapeutic target for triple negative breast cancer and exhibited powerful capacity of AuNR-P17 in photothermal immune therapy. • AuNR-P17 can bind to HSP60 overexpressed by breast cancer tumor cells. • AuNR-P17 reduces HSP60 to overcomes heat resistance of the tumor cells. • Photothermal interaction on HSP60 exert specific immune responses against the tumor.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Heat shock proteins research · Nanoplatforms for cancer theranostics · Endoplasmic Reticulum Stress and Disease

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (49)

Show source-provided references
2. Advancements in clinical aspects of targeted therapy and immunotherapy in breast cancer10.1186/s12943-023-01805-y ↗
3. Understanding and treating triple-negative breast cancer
4. Alarming burden of triple-negative breast cancer in India10.1016/j.clbc.2017.07.013 ↗
5. Triple-negative breast cancer molecular subtyping and treatment progress10.1186/s13058-020-01296-5 ↗
6. Cytosolic heat shock protein 60, apoptosis, and myocardial injury10.1161/01.CIR.0000019403.35847.23 ↗
7. Hsp10 and Hsp60 modulate Bcl-2 family and mitochondria apoptosis signaling induced by doxorubicin in cardiac muscle cells10.1016/S0022-2828(03)00229-3 ↗
8. Lenti-siRNA Hsp60 promote bax in mitochondria and induces apoptosis during heat stress10.1016/j.bbrc.2016.10.153 ↗
9. HSP90 inhibitor encapsulated photo-theranostic nanoparticles for synergistic combination cancer therapy10.7150/thno.14882 ↗
10. Enhanced photothermal therapy through the in situ activation of a temperature and redox dual-sensitive nanoreservoir of triptolide10.1002/smll.202003398 ↗
11. Enhanced ROS-boosted phototherapy against pancreatic cancer via nrf2-mediated stress-defense pathway suppression and ferroptosis induction10.1021/acsami.1c22861 ↗
12. Organelle-targeted photothermal agents for cancer therapy10.1039/D1CC02168K ↗
13. Mitochondrion, lysosome, and endoplasmic reticulum: which is the best target for phototherapy?10.1016/j.jconrel.2022.09.037 ↗
14. Targeting tumor glycolysis by a mitotropic agent10.1517/14728222.2016.1093114 ↗
15. NIR-emitting and photo-thermal active nanogold as mitochondria-specific probes10.1039/C6BM00951D ↗
16. S-nitrosothiols loaded mini-sized Au@silica nanorod elicits collagen depletion and mitochondrial damage in solid tumor treatment10.7150/thno.42661 ↗
17. Dog-bone shaped gold nanoparticle-mediated chemo-photothermal therapy impairs the powerhouse to trigger apoptosis in cancer cells10.1039/D3TB01716H ↗
18. Nucleus and mitochondria targeting theranostic plasmonic surface-enhanced Raman spectroscopy nanoprobes as a means for revealing molecular stress response differences in hyperthermia cell death between cancerous and normal cells10.1021/acs.analchem.8b03034 ↗
19. Induction of apoptosis in human cancer cells by targeting mitochondria with gold nanoparticles10.1039/C5NR01483B ↗
20. Activation of mitochondrial unfolded protein response is associated with Her2-overexpression breast cancer10.1007/s10549-020-05729-9 ↗
21. The chaperone system in breast cancer: roles and therapeutic prospects of the molecular chaperones Hsp27, Hsp60, Hsp70, and Hsp9010.3390/ijms23147792 ↗
22. Clinical, prognostic and therapeutic significance of heat shock proteins in cancer10.2174/1389450118666170823121248 ↗
23. Hsp60 expression, new locations, functions and perspectives for cancer diagnosis and therapy10.4161/cbt.7.6.6281 ↗
24. A HSP60-targeting peptide for cell apoptosis imaging10.1038/oncsis.2016.14 ↗
25. Copper-ion-assisted growth of gold nanorods in seed-mediated growth: significant narrowing of size distribution via tailoring reactivity of seeds10.1021/la304181k ↗
26. Probing the behaviors of gold nanorods in metastatic breast cancer cells based on UV-vis-NIR absorption spectroscopy
27. Vanadyl ions binding to GroEL (HSP60) and inducing its depolymerization10.1007/s11434-007-0380-0 ↗
28. Constructing virus-like SiO(x)/CeO(2)/VO(x) nanozymes for 1064 nm light-triggered mild-temperature photothermal therapy and nanozyme catalytic therapy10.1039/D1NR06128C ↗
29. Identification of heat shock protein 60 as a molecular mediator of alpha 3 beta 1 integrin activation
30. Integrin α3β1 promotes invasive and metastatic properties of breast cancer cells through induction of the brn-2 transcription factor10.3390/cancers13030480 ↗
31. Single-cell chemistry of photoactivatable platinum anticancer complexes10.1021/jacs.1c08630 ↗
32. Visualization of a mammalian mitochondrion by coherent X-ray diffractive imaging10.1038/s41598-017-01833-x ↗
33. X-ray tomography of whole cells10.1016/j.sbi.2005.08.008 ↗
34. Quantitative analysis of yeast internal architecture using soft X-ray tomography10.1002/yea.1834 ↗
35. Mitochondria as key components of the stress response10.1016/j.tem.2007.04.004 ↗
36. Ultrasound (US)-activated redox dyshomeostasis therapy reinforced by immunogenic cell death (ICD) through a mitochondrial targeting liposomal nanosystem10.7150/thno.62984 ↗
37. Oxidative stress amplifiers as immunogenic cell death nanoinducers disrupting mitochondrial redox homeostasis for cancer immunotherapy10.1002/adhm.202202710 ↗
38. Murine mammary carcinoma 4T1 induces a leukemoid reaction with splenomegaly: association with tumor-derived growth factors10.1016/j.yexmp.2006.06.007 ↗
39. Therapeutic targeting with DABIL-4 depletes myeloid suppressor cells in 4T1 triple-negative breast cancer model10.1002/1878-0261.12938 ↗
40. Tumor microenvironment: key players in triple negative breast cancer immunomodulation10.3390/cancers13133357 ↗
41. Near-infrared light-triggered platelet arsenal for combined photothermal-immunotherapy against cancer10.1126/sciadv.abd7614 ↗
42. Carbon nanotubes conjugated to tumor lysate protein enhance the efficacy of an antitumor immunotherapy10.1002/smll.200701059 ↗
43. Toward developing chemical modulators of Hsp60 as potential therapeutics10.3389/fmolb.2018.00035 ↗
44. The multiple roles and therapeutic potential of HSP60 in cancer10.1016/j.bcp.2022.115096 ↗
45. Enhanced photothermal therapy through the in situ activation of a temperature and redox dual-sensitive nanoreservoir of triptolide10.1002/smll.202003398 ↗
46. Integrin α3β1 represses reelin expression in breast cancer cells to promote invasion10.3390/cancers13020344 ↗
47. Immunogenic cell death in cancer therapy10.1146/annurev-immunol-032712-100008 ↗
48. Immunogenic cell death and DAMPs in cancer therapy10.1038/nrc3380 ↗
49. Recent advances in therapeutic strategies for triple-negative breast cancer10.1186/s13045-022-01341-0 ↗